Varian Medical Systems on Oct. 20 unveiled Trilogy, an image-guided radiation therapy system at the annual meeting of the American Society of Therapeutic Radiology and Oncology in Salt Lake City. The work-in-progress is optimized for conventional and
Varian Medical Systems on Oct. 20 unveiled Trilogy, an image-guided radiation therapy system at the annual meeting of the American Society of Therapeutic Radiology and Oncology in Salt Lake City. The work-in-progress is optimized for conventional and stereotactic approaches to treating cancer. Trilogy is designed to deliver 3D conformal radiotherapy, intensity-modulated radiation therapy, stereotactic radiosurgery, fractionated stereotactic radiation therapy, and intensity-modulated radiosurgery for cancer and neurosurgical treatments. At its core is an enhanced version of Varian's 23EX Clinac linear accelerator capable of stereotactic applications that involve delivering higher doses of radiation to smaller areas over a shorter period of time.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.